Esperion Therapeutics
ESPR
#6399
Rank
$0.80 B
Marketcap
$3.39
Share price
-4.51%
Change (1 day)
89.39%
Change (1 year)

Market capitalization of Esperion Therapeutics (ESPR)

Market cap: $0.80 Billion USD

As of February 2026 Esperion Therapeutics has a market cap of $0.80 Billion USD. This makes Esperion Therapeutics the world's 6399th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Esperion Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026$0.80 B-16.09%
2025$0.95 B113.2%
2024$0.44 B32.12%
2023$0.34 B-25.93%
2022$0.45 B50.75%
2021$0.30 B-54.81%
2020$0.67 B-58.91%
2019$1.63 B32.88%
2018$1.23 B-28.46%
2017$1.72 B510.84%
2016$0.28 B-43.66%
2015$0.50 B-39.08%
2014$0.82 B290.3%
2013$0.21 B

End of Day market cap according to different sources

On Jan 31st, 2026 the market cap of Esperion Therapeutics was reported to be:

$0.81 Billion USD
by Nasdaq info icon info icon
$0.80 Billion USD
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
$150.33 B 18,605.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
$78.58 B 9,678.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
$2.32 B 188.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
$0.42 B-47.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
$4.48 B 457.80%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$10.86 B 1,251.58%๐Ÿ‡บ๐Ÿ‡ธ USA